Albumin-bilirubin index and platelet-albumin-bilirubin index contribute to identifying survival benefit candidates in patients with hepatocellular carcinoma and Child-Pugh grade A undergoing transcatheter arterial chemoembolization with sorafenib treatment

BACKGROUND: Combined therapy of transcatheter arterial chemoembolization (TACE) with sorafenib is used for a large number of patients with intermediate-stage or advanced-stage hepatocellular carcinoma (HCC), but its implementation is limited by the evaluation of pre-treatment liver function reserve....

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Keshu, Yuan, Jia, Tang, Bei, Zhang, Feng, Lu, Shenxin, Chen, Rongxin, Zhang, Lan, Ren, Zhenggang, Yin, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7940911/
https://www.ncbi.nlm.nih.gov/pubmed/33708864
http://dx.doi.org/10.21037/atm-20-3118

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7940911/
https://www.ncbi.nlm.nih.gov/pubmed/33708864
http://dx.doi.org/10.21037/atm-20-3118

Ejemplares similares